Also known as Rapaflo
Silodosin (trade names Rapaflo (USA), Silodyx (Europe), Rapilif (India), Silodal (India), Urief (Japan)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).Source: Wikipedia
Estimated Total Cost: $99.02 for an average of 28 days supply
Patients are most commonly prescribed silodosin to treat benign prostatic hyperplasia (bph), retention of urine, frequent urination, and kidney stone.